SCHEMBL17418047

SCHEMBL17418047

COC(=O)c1ccc(CCO)c(-c2ccc(OCCCS(C)(=O)=O)cc2OC)c1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.39
PIK3CG P48736 1/20 0.38
NPC1 O15118 1/20 0.38
PTGS2 P35354 1/20 0.38
FFAR1 O14842 4/20 0.37
FFAR4 Q5NUL3 2/20 0.37
CYP2C9 P11712 1/20 0.37
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
ALDH1A1 P00352 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PDE4B Q07343 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17418022 0.90 NPC1 (0.42) MAPTPIK3CGNPC1PTGS2FFAR1
SCHEMBL17432105 0.89 MAPT (0.43) MAPTNPC1RAB9AKMT2AALDH1A1
SCHEMBL17386321 0.80 L3MBTL1 (0.47) MAPTFFAR1KMT2ACYP4F2CYP4A11
SCHEMBL17429676 0.78 NPC1 (0.46) MAPTNPC1RAB9AKMT2ACYP4F2
SCHEMBL17386025 0.78 ALDH1A1 (0.48) MAPTNPC1CYP2C9RAB9AKMT2A
SCHEMBL17417955 0.75 PSMD10 (0.42) MAPTPTGS2FFAR1FFAR4CYP2C9
SCHEMBL17386175 0.74 KDM4E (0.46) MAPTNPC1RAB9AALDH1A1L3MBTL1
SCHEMBL1795779 0.74 MAPT (0.70) MAPTNPC1RAB9AKMT2AALDH1A1
SCHEMBL17386360 0.74 RAB9A (0.42) MAPTNPC1FFAR1RAB9AKMT2A
SCHEMBL765490 0.73 FFAR1 (0.49) FFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 US disclosed
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 US disclosed
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF GPR65, GPR119, GPR35 MAPT 2131/4885PIK3CG 3430/4885NPC1 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.